Developing a novel class of drugs to treat life‐threatening systemic fungal infections.
- Year invested 2015
- Investment Stage Early
- Sectors
- Investment Status Historic
- Associated Team
- Website amplyx.com/
- Company Status Acquired (by Pfizer)
Developing a novel class of drugs to treat life‐threatening systemic fungal infections.